Raziye Piranlioglu, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunity | 1 | 2019 | 1002 | 0.420 |
Why?
|
| Glioblastoma | 4 | 2023 | 3458 | 0.290 |
Why?
|
| Oncolytic Virotherapy | 2 | 2023 | 520 | 0.290 |
Why?
|
| Oncolytic Viruses | 1 | 2023 | 344 | 0.160 |
Why?
|
| Tail | 1 | 2019 | 91 | 0.160 |
Why?
|
| Antigen Presentation | 1 | 2023 | 1250 | 0.150 |
Why?
|
| Herpesvirus 1, Human | 1 | 2023 | 743 | 0.150 |
Why?
|
| Lymphocyte Subsets | 1 | 2019 | 313 | 0.150 |
Why?
|
| Tumor Escape | 1 | 2021 | 371 | 0.150 |
Why?
|
| Multipotent Stem Cells | 1 | 2019 | 200 | 0.140 |
Why?
|
| Mammary Glands, Animal | 1 | 2019 | 273 | 0.140 |
Why?
|
| Genetic Pleiotropy | 1 | 2018 | 182 | 0.140 |
Why?
|
| Brain Neoplasms | 3 | 2023 | 9101 | 0.140 |
Why?
|
| Tumor Microenvironment | 4 | 2023 | 3942 | 0.130 |
Why?
|
| Exosomes | 1 | 2021 | 417 | 0.130 |
Why?
|
| Neoplasms | 3 | 2021 | 22350 | 0.130 |
Why?
|
| Granulocytes | 1 | 2017 | 551 | 0.120 |
Why?
|
| Veins | 1 | 2019 | 769 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 3610 | 0.110 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 17089 | 0.100 |
Why?
|
| Neoplasm Metastasis | 2 | 2019 | 4892 | 0.090 |
Why?
|
| Survival Analysis | 2 | 2023 | 10101 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2021 | 4652 | 0.080 |
Why?
|
| Glioma | 1 | 2023 | 3498 | 0.070 |
Why?
|
| Monocytes | 1 | 2017 | 2599 | 0.070 |
Why?
|
| Myeloid Cells | 2 | 2023 | 838 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 4349 | 0.070 |
Why?
|
| Epithelial Cells | 1 | 2019 | 3698 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2018 | 3600 | 0.070 |
Why?
|
| Stem Cells | 1 | 2019 | 3536 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2019 | 10451 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 18329 | 0.060 |
Why?
|
| Mice | 6 | 2023 | 81898 | 0.060 |
Why?
|
| STAT Transcription Factors | 1 | 2023 | 189 | 0.050 |
Why?
|
| Models, Biological | 1 | 2019 | 9464 | 0.050 |
Why?
|
| Janus Kinases | 1 | 2023 | 253 | 0.050 |
Why?
|
| Animals | 8 | 2023 | 168939 | 0.050 |
Why?
|
| Kynurenine | 1 | 2023 | 142 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 8623 | 0.050 |
Why?
|
| Oximes | 1 | 2023 | 305 | 0.050 |
Why?
|
| Tryptophan | 1 | 2023 | 484 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9528 | 0.050 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2021 | 115 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11876 | 0.040 |
Why?
|
| Purine Nucleosides | 1 | 2018 | 30 | 0.040 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 2018 | 40 | 0.040 |
Why?
|
| Immunotherapy | 2 | 2023 | 4747 | 0.030 |
Why?
|
| Macrophages | 2 | 2021 | 5784 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 2018 | 748 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2023 | 3157 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2021 | 3618 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2017 | 496 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 872 | 0.030 |
Why?
|
| Microglia | 1 | 2023 | 1370 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 1836 | 0.030 |
Why?
|
| Cell Communication | 1 | 2021 | 1660 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 754 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 2626 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 21162 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 1349 | 0.020 |
Why?
|
| Humans | 8 | 2023 | 766812 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2018 | 3738 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2023 | 23618 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 6225 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2021 | 8728 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 10263 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2021 | 14473 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 20146 | 0.020 |
Why?
|
| Apoptosis | 1 | 2018 | 9514 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2019 | 11657 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2017 | 18986 | 0.010 |
Why?
|
| Female | 4 | 2021 | 396532 | 0.010 |
Why?
|
| Inflammation | 1 | 2018 | 10863 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 22351 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2023 | 65286 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 13489 | 0.010 |
Why?
|
| Male | 1 | 2021 | 364154 | 0.000 |
Why?
|